Live Status Check

NCT07611110 Recruiting Status

Q: What is the status of clinical trial NCT07611110?

NCT07611110 is currently recruiting. This is a PHASE3 study for metastatic castration-resistant prostate cancer sponsored by AstraZeneca. Status verified from ClinicalTrials.gov.

Q: Where is NCT07611110 recruiting?

NCT07611110 is recruiting at 26 locations across the United States.

Q: How do I enroll in NCT07611110?

To enroll in NCT07611110, check your eligibility on HelloStudys.com and complete the interest form. A coordinator will contact you about next steps.

Real-time enrollment status for this metastatic castration-resistant prostate cancer clinical trial

Current Status

Recruiting

Auto-verified from ClinicalTrials.gov

Checked: August 28, 2026 at 12:02 AM UTC

NCT07611110 Status Summary

NCT Number	NCT07611110
Recruiting Status	Recruiting
Condition	Metastatic Castration-resistant Prostate Cancer
Phase	PHASE3
Target Enrollment	670 participants
Active Locations	26 sites in the US
Sponsor	AstraZeneca
Last Updated on CT.gov	August 26, 2026 (2 days ago)

About NCT07611110 Enrollment Status

As of August 28, 2026: Clinical trial NCT07611110 is currently recruiting participants. This phase3 study for metastatic castration-resistant prostate cancer is actively seeking new participants at 26 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.

Frequently Asked Questions About NCT07611110

Is NCT07611110 still recruiting?

Yes, NCT07611110 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.

Where is NCT07611110 recruiting?

This trial is recruiting at 26 locations in the United States. View all available locations on the full study page.

How do I enroll in NCT07611110?

Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.

When was NCT07611110 status last updated?

The official ClinicalTrials.gov record for NCT07611110 was last updated 2 days ago (August 26, 2026). HelloStudys verifies this status automatically.

Browse More Metastatic Castration-resistant Prostate Cancer Trials

Prostate Cancer Trials Essential Tremor Trials Rheumatoid Arthritis Trials Ankylosing Spondylitis Trials Interstitial Cystitis Trials Myalgic Encephalomyelitis Trials All Conditions →

Ready to Apply?

Check your eligibility for this clinical trial